Report cover image

Asia Pacific Medical Foods for Inborn Errors of Metabolism Market

Publisher Data Bridge Market Research
Published Apr 01, 2024
Length 360 Pages
SKU # DAABD18813146

Description

Asia Pacific Medical Foods for Inborn Errors of Metabolism Market


Asia-Pacific medical foods for inborn errors of metabolism market is expected to reach USD 1,671.46 million by 2031 from USD 425.67 million in 2022, growing at a CAGR of 16.7% during the forecast period of 2023 to 2031.
Market Segmentation:
Asia-Pacific Medical Foods For Inborn Errors Of Metabolism Market, By Products (Amino Acid, Low Protein Food, Glytactin with GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, and Others), Diseases (Phenylketonuria (PKU), Ryrosinemia Types I And II, Maple Syrup Urine Disease (MSUD), Homocystinuria, Glutaric Acidemia Type I, Urea Cycle Disorders, Methylmalonic Acidemia, Isovaleric Acidemia, Organic Acidurias, Renal Disease, Propionic Academia, Disorders Of Leucine Metabolism, and Others), Age Group (Infants, Weaning, Adolescent, and Adults), Forms (Powder, Liquid, Tablets , Gels, and Others), Packaging (Can, Jar, Packets, Bottle, and Others), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy, Drugs Store, and Others), Country (China, Japan, India, Australia, South Korea, Thailand, Singapore, Indonesia, Malaysia, New Zealand, Vietnam, Philippines, Taiwan, rest of Asia-Pacific) – Industry Trends and Forecast to 2031

Overview of Asia-Pacific Medical Foods for Inborn Errors of Metabolism Market Dynamics:

Drivers
• Rising incidence of inborn errors of metabolism
• Rising preference of dietary supplements over enzyme replacement therapy
• Increase in the number of new born screening procedures
• Increasing spending on medical food products
Restraints
• High cost of medical food
• Stringent regulations for medical foods
Opportunities
• Government initiatives and programs for creating awareness about IEM
• Increasing collaboration and partnerships in the market
• Expansion of medical foods in emerging market
Challenges
• Poor accessibility of medical foods
• Alternative treatment approaches for inborn errors of metabolism



Market Players:

The key market players operating in the Asia-Pacific medical foods for inborn errors of metabolism market are listed below:
• Abbott
• Nestlé Health Science
• Meiji Holdings Co., Ltd
• Baxter
• Pristine Organics Pvt Ltd.
• Promin
• Solace Nutrition
• EBM Medical, Galen Limited
• Hexagon Nutrition Ltd.
• Kate Farms
• Ajinomoto Cambrooke, Inc.
• Mead Johnson & Company, LLC.
• Nutricia
• B. Braun SE
• Orpharma Pty Ltd.
• Piam Farmaceutici S.P.A.
• PKU-Mdmil.com
• Primus Pharmaceuticals, inc.
• Biovencer Healthcare Pvt Ltd

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

360 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 DBMR Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 DBMR Market Position Grid
2.8 Secondary Sources
2.9 Assumptions
3 Executive Summary
4 Premium Insight
4.1 Epidemiology
4.1.1 Prevalence Of Inborn Errors Of Metabolism
4.1.2 New-born Screening Programs
4.1.3 Genetic Heterogeneity
4.1.4 Impact On Health
4.1.5 Clinical Impac
4.1.6 Treatment And Management
4.2 Pestle Analysis
4.2.1 Political Factors
4.2.2 Economic Factors
4.2.3 Social Factors
4.2.4 Technological Factors
4.2.5 Environmental Factors
4.2.6 Legal Factors
4.3 Porter’s Five Forces
4.3.1 Threat Of New Entrants
4.3.2 Threat Of Substitutes
4.3.3 Bargaining Power Of Buyers
4.3.4 Bargaining Power Of Suppliers
4.3.5 Competitive Rivalry
4.4 Industry Insights
4.4.1 Demographic Trends
4.4.2 Key Pricing Strategies
4.4.3 Key Patient Enrollment Strategies
4.5 Patent Analysis
4.6 Pipeline Analysis
4.6.1 Research And Development
4.6.2 Clinical Trials
4.6.3 Regulatory Approval
4.6.4 Manufacturing And Production
4.6.5 Commercialization And Market Access
4.6.6 Distribution And Supply Chain Management
4.6.7 Post-market Surveillance And Monitoring
4.7 Regulation Coverage
5 Market Overview
5.1 Drivers
5.1.1 Rising Incidences Of Inborn Errors Of Metabolism (Iem)
5.1.2 Rising Preference For Dietary Supplements Over Enzyme Replacement Therapy (Ert)
5.1.3 Increase In The Number Of New-born Screening Procedures
5.1.4 Increasing Spending On Medical Food Products
5.2 Restraints
5.2.1 High Cost Of Medical Foods
5.2.2 Stringent Regulations For Medical Foods
5.3 Opportunities
5.3.1 Government Initiatives And Programs For Creating Awareness About Inborn Errors Of Metabolism
5.3.2 Increasing Collaborations And Partnerships In The Market
5.3.3 Expansion Of Medical Foods In Emerging Markets
5.4 Challenges
5.4.1 Poor Accessibility Of Medical Foods
5.4.2 Alternative Treatment Approaches For Inborn Errors Of Metabolism
6 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Products
6.1 Overview
6.2 Amino Acid
6.2.1 Amino Acid, By Products
6.2.1.1 Amino Acid Mixtures, By Products
6.2.1.2 Phenylade, By Products
6.2.1.1 Single Amino Acids, By Products
6.3 Low Protein Food
6.3.1 Low Protein Food, By Products
6.4 Glytactin With Gmp Amino Acid-modified Infant Formula With Iron
6.4.1 Glytactin With Gmp Amino Acid-modified Infant Formula With Iron, By Flavors
6.4.2 Glytactin With Gmp Amino Acid-modified Infant Formula With Iron, By Usages
6.5 Low-calcium/Vitamin D-free Infant Formula With Iron
6.5.1 Low-calcium/Vitamin D-free Infant Formula With Iron, By Products
6.6 Others
7 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Diseases
7.1 Overview
7.2 Phenylketonuria (Pku)
7.2.1 Phenylketonuria (Pku), By Diseases
7.3 Tyrosinemia Types I And Ii
7.4 Maple Syrup Urine Disease (Msud)
7.4.1 Maple Syrup Urine Disease (Msud), By Diseases
7.5 Homocystinuria
7.5.1 Glutaric Acidemia Type I
7.6 Urea Cycle Disorders
7.6.1 Urea Cycle Disorders, By Diseases
7.7 Methylmalonic Acidemia
7.7.1 Isovaleric Acidemia
7.8 Organic Acidurias
7.9 Renal Disease
7.10 Propionic Acidemia
7.11 Disorders Of Leucine Metabolism
7.12 Others
8 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Age Group
8.1 Overview
8.2 Infants
8.3 Weaning
8.4 Adolescent
8.5 Adults
9 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Forms
9.1 Overview
9.2 Powder
9.3 Liquid
9.4 Tablets
9.5 Gels
9.6 Others
10 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Packaging
10.1 Overview
10.2 Can
10.3 Packets
10.4 Bottle
10.5 Jar
10.6 Others
11 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel
11.1 Overview
11.2 Hospital Pharmacy
11.3 Retail Pharmacy
11.4 Drug Stores
11.5 Online Pharmacy
11.6 Others
12 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Region
12.1 Asia-pacific
12.1.1 China
12.1.2 Japan
12.1.3 India
12.1.4 Australia
12.1.5 South Korea
12.1.6 Thailand
12.1.7 Singapore
12.1.8 Indonesia
12.1.9 Malasia
12.1.10 New Zealand
12.1.11 Vietnam
12.1.12 Philippines
12.1.13 Taiwan
12.1.14 Rest Of Asia-pacific
13 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: Company Landscape
13.1 Company Share Analysis: Asia-pacific
14 Swot Analysis
15 Company Profile
15.1 Abbott
15.1.1 Company Snapshot
15.1.2 Revenue Analysis
15.1.3 Company Share Analysis
15.1.4 Product Portfolio
15.1.5 Recent Development
15.2 Nestlé Health Science (A Subsidiary Of Nestlé)
15.2.1 Company Snapshot
15.2.2 Company Share Analysis
15.2.3 Product Portfolio
15.2.4 Recent Developments
15.3 Meiji Holdings Co., Ltd.
15.3.1 Company Snapshot
15.3.2 Revenue Analysis
15.3.3 Company Share Analysis
15.3.4 Product Portfolio
15.3.5 Recent Developments
15.4 Baxter
15.4.1 Company Snapshot
15.4.2 Revenue Analysis
15.4.3 Company Share Analysis
15.4.4 Product Portfolio
15.4.5 Recent Development
15.5 Pristine Organics Pvt Ltd.
15.5.1 Company Snapshot
15.5.2 Company Share Analysis
15.5.3 Product Portfolio
15.5.4 Recent Development
15.6 Ajinomoto Cambrooke, Inc. (A Subsidiary Of Ajinomoto Co., Inc.)
15.6.1 Company Snapshot
15.6.2 Product Portfolio
15.6.3 Recent Developments
15.7 B.Braun Se
15.7.1 Company Snapshot
15.7.2 Product Portfolio
15.7.3 Recent Development
15.8 Biovencer Healthcare Pvt Ltd
15.8.1 Company Snapshot
15.8.2 Product Portfolio
15.8.3 Recent Development
15.9 Ebm Medical
15.9.1 Company Snapshot
15.9.2 Product Portfolio
15.9.3 Recent Development
15.10 Galen Limited
15.10.1 Company Snapshot
15.10.2 Product Portfolio
15.10.3 Recent Developments
15.11 Hexagon Nutrition Ltd.
15.11.1 Company Snapshot
15.11.2 Product Portfolio
15.11.3 Recent Development
15.12 Kate Farms
15.12.1 Company Snapshot
15.12.2 Product Portfolio
15.12.3 Recent Developments
15.13 Mead Johnson & Company, Llc. (A Subsidiary Of Reckitt Benckiser Group Plc.)
15.13.1 Company Snapshot
15.13.2 Product Portfolio
15.13.3 Recent Development
15.14 Nutricia (A Subsidiary Of Danone)
15.14.1 Company Snapshot
15.14.2 Product Portfolio
15.14.3 Recent Development
15.15 Orpharma Pty Ltd.
15.15.1 Company Snapshot
15.15.2 Product Portfolio
15.15.3 Recent Development
15.16 Piam Farmaceutici S.P.A
15.16.1 Company Snapshot
15.16.2 Product Portfolio
15.16.3 Recent Development
15.17 Pku-mdmil
15.17.1 Company Snapshot
15.17.2 Product Portfolio
15.17.3 Recent Development
15.18 Primus Pharmaceuticals, Inc.
15.18.1 Company Snapshot
15.18.2 Product Portfolio
15.18.3 Recent Development
15.19 Promin
15.19.1 Company Snapshot
15.19.2 Product Portfolio
15.19.3 Recent Development
15.20 Solace Nutrition
15.20.1 Company Snapshot
15.20.2 Product Portfolio
15.20.3 Recent Development
16 Questionnaire
17 Related Reports
Table 1 Costs Of Medical Foods Used In Inborn Errors Of Metabolism (Iems)
Table 2 Patent Analysis
Table 3 Regulatory Coverage
Table 4 Costs Of Medical Foods
Table 5 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 6 Asia-pacific Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 7 Asia-pacific Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 8 Asia-pacific Amino Acids Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 9 Asia-pacific Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 10 Asia-pacific Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 11 Asia-pacific Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 12 Asia-pacific Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 13 Asia-pacific Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 14 Asia-pacific Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 15 Asia-pacific Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 16 Asia-pacific Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 17 Asia-pacific Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 18 Asia-pacific Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 19 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 20 Asia-pacific Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 21 Asia-pacific Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 22 Asia-pacific Tyrosinemia Types I And Ii In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 23 Asia-pacific Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 24 Asia-pacific Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 25 Asia-pacific Homocystinuria In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 26 Asia-pacific Glutaric Acidemia Type I In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 27 Asia-pacific Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 28 Asia-pacific Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 29 Asia-pacific Methylmalonic Acidemia In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 30 Asia-pacific Isovaleric Acidemia In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 31 Asia-pacific Organic Acidurias In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 32 Asia-pacific Renal Disease In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 33 Asia-pacific Propionic Acidemia In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 34 Asia-pacific Disorders Of Leucine Metabolism In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 35 Asia-pacific Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 36 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 37 Asia-pacific Infants In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 38 Asia-pacific Weaning In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 39 Asia-pacific Adolescent In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 40 Asia-pacific Adults In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 41 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 42 Asia-pacific Powder In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 43 Asia-pacific Liquid In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 44 Asia-pacific Tablets In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 45 Asia-pacific Gels In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 46 Asia-pacific Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 47 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 48 Asia-pacific Can In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 49 Asia-pacific Liquid In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 50 Asia-pacific Bottle In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 51 Asia-pacific Jar In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 52 Asia-pacific Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 53 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 54 Asia-pacific Hospital Pharmacy In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 55 Asia-pacific Retail Pharmacy In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 56 Asia-pacific Drug Stores In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 57 Asia-pacific Online Pharmacy In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 58 Asia-pacific Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 59 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Country, 2018-2031 (Usd Thousand)
Table 60 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 61 Asia-pacific Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 62 Asia-pacific Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 63 Asia-pacific Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 64 Asia-pacific Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 65 Asia-pacific Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 66 Asia-pacific Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 67 Asia-pacific Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 68 Asia-pacific Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 69 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 70 Asia-pacific Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 71 Asia-pacific Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 72 Asia-pacific Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 73 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 74 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 75 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 76 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 77 China Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 78 China Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 79 China Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 80 China Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 81 China Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 82 China Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 83 China Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 84 China Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 85 China Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 86 China Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 87 China Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 88 China Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 89 China Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 90 China Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 91 China Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 92 China Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 93 China Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 94 Japan Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 95 Japan Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 96 Japan Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 97 Japan Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 98 Japan Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 99 Japan Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 100 Japan Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 101 Japan Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 102 Japan Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 103 Japan Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 104 Japan Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 105 Japan Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 106 Japan Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 107 Japan Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 108 Japan Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 109 Japan Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 110 Japan Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 111 India Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 112 India Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 113 India Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 114 India Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 115 India Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 116 India Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 117 India Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 118 India Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 119 India Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 120 India Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 121 India Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 122 India Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 123 India Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 124 India Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 125 India Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 126 India Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 127 India Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 128 Australia Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 129 Australia Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 130 Australia Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 131 Australia Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 132 Australia Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 133 Australia Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 134 Australia Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 135 Australia Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 136 Australia Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 137 Australia Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 138 Australia Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 139 Australia Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 140 Australia Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 141 Australia Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 142 Australia Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 143 Australia Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 144 Australia Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 145 South Korea Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 146 South Korea Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 147 South Korea Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 148 South Korea Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 149 South Korea Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Figure 1 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: Segmentation
Figure 2 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: Data Triangulation
Figure 3 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: Droc Analysis
Figure 4 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: Asia-pacific Vs Regional Market Analysis
Figure 5 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: Company Research Analysis
Figure 6 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: Interview Demographics
Figure 7 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: Dbmr Market Position Grid
Figure 8 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: Segmentation
Figure 9 A Rise In The Incidence Of Inborn Errors Of Metabolism And An Increase In The Number Of The Newborn Screening Procedures Are Expected To Drive The Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market Growth In The Forecast Period Of 2023 To 2031
Figure 10 The Amino Acid Segment Is Expected To Account For The Largest Share Of The Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market In 2023 And 2031
Figure 11 Epidemiology
Figure 12 Porter’s Five Forces
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market
Figure 14 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: By Products, 2022
Figure 15 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: By Diseases, 2022
Figure 16 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: By Age Group, 2022
Figure 17 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: By Forms, 2022
Figure 18 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: By Packaging, 2022
Figure 19 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: By Distribution Channel, 2022
Figure 20 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market:snapshot (2022)
Figure 21 Asia-pacific Medical Foods For Inborn Errors Of Metabolism Market: Company Share 2023 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us